EFNB2 and neoplasm: Another study showed that EphB4 and ephrinB2 are expressed by ECs of human malignant brain tumors and overexpression of different EphB4 variants in blood vessels in tumor xenografts leads to the assumption that EphB4 acts as negative regulator of blood vessel branching and vascular network formation [102].